Tag:
Latest content
- AstraZeneca and Daiichi Sankyo’s Datroway given FDA Priority Review for breast cancer treatment
- With compassion
- Spyre Therapeutics appoints Kate Tansey Chevlen as Chief Commercial Officer
- UCB releases new data on Bimzelx for hidradenitis suppurativa
- Sagimet announces positive results for Ascletis’ denifanstat in moderate to severe acne
Latest intelligence
- ASH 2025: where Magic Kingdom met the spirit of Andor
- Alzheimer’s disease – the future of diagnosis and treatment in Europe
- Clinical trials on dementia: bridging access and innovation
- The trust crisis: how pharma must evolve to engage Gen Z HCPs
- Setting out – why omnichannel success is about orchestration